Search Results

ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.

After more than two decades of attempts to develop a universal influenza vaccine, the global COVID-19 pandemic intensified the need for a broader vaccine for both illnesses.

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

Selexis SA , a JSR Life Sciences Company, today announced key promotions across its scientific and operational leadership teams. Effective immediately, the following individuals have been promoted: Myriam Adam, PhD, to vice president, operations and intellectual property; Séverine Fagète, PhD, to vice president, cell line development services; and Valérie Le Fourn, PhD, to vice president, research. “Amid this gl